Biologically-Active Medical Devices Manufactured from Blood Plasma
Carmell Therapeutics is developing biologically-active medical devices, with growth and regenerative factors designed by nature in the right proportions to heal tissues.News
4/19/13 Can New Plasma-Based Biomaterials Speed Healing of Injured Tissues?
New Rochelle, NY, April 15, 2013—Platelet-rich plasma (PRP) derived from blood contains growth factors and other bioactive molecules that promote he[...]
6/21/11 Tragic Death of Mike Egan June 18
Mike Egan, one of Carmell's newest board members, died tragically on June 18 in a bicycle accident while on vacation in Norway. At the time of the ac[...]
4/24/11 NEWS RELEASE - Carmell Therapeutics Completes Series A Financing to Advance the Development of Novel Bioactive Plastics
Pittsburgh, PA – April 15, 2011 – Carmell Therapeutics, a company that manufactures novel blood plasma-based biomaterials that accelerate the repa[...]
